Potential
Major advances in organ-specific imagingThe article by Bocher et al. in this issue [1] reports on the performance of a novel SPECT system specifically designed for cardiac imaging based on the use of a set of pinhole collimators in combination with cadmium zinc telluride (CZT) detectors. The system is inspired by earlier work on multipinhole imaging [2] and the conceptual design has previously been demonstrated in simulation studies [3]. Also early clinical validation studies have appeared recently [4,5]. The described system (available from GE Healthcare) joins a range of novel organ-specific commercial systems that have recently been introduced to the consumer with reported improvement in resolution and sensitivity (usually reported as potential for reduced acquisition time; see recent reviews [6,7]). Specific examples are the D-SPECT from Spectrum Dynamics [8,9] and the Cardius from Digirad [10]. Clinical validation studies for these systems are now also appearing (e.g. [11,12]). The developers of these systems deserve congratulations for introducing innovations that undoubtedly yield the largest advance in SPECT performance since the introduction of the rotating gamma camera, which has dominated clinical use for several decades. Until recently the development in SPECT performance has been incremental, mainly involving refinement rather than major changes in system design, perhaps mainly due to the clinical demand for systems that offer flexibility in application. The recent innovation has been inspired at least partly by the rapid developments in preclinical imaging systems where ultrahigh resolution and relatively high sensitivity have been demonstrated. Bringing new designs to fruition has only been possible due to the combination of several factors: the improved reliability of alternative detector materials, the development of fast electronics, the development of efficient reconstruction algorithms and, not least, the demand for organ-specific systems where optimization for a specific purpose rather than flexibility in application is indicated.
CZT: pros and consCentral to the design of both the GE Healthcare system and the D-SPECT is the use of CZT. Although not a new detector material, it is only recently that the reliability and performance of CZT at room temperature have been sufficiently improved to make clinical use a possibility. The cost of CZT remains relatively high and places a constraint on the possible designs. But the appeal is not just the much improved energy resolution (typically 5-6%) but particularly the small size that facilitates novel compact designs, which are very much appealing for use in organspecific imaging. There are alternative approaches to achieving compact designs based on conventional scintillation detectors coupled to optical readout systems other than conventional photomultiplier tubes (e.g. avalanche photodiode or silicon photomultiplier), which may have a cost advantage (see [13] for a useful overview). We can anticipate increasing use of new technology in f...